7-Year Clinical Trial Shows Synergistic Effects of Combined Telmisartan-Rosuvastatin Therapy in Preventing Dementia Among Elderly Hypertensive Patients, with Enhanced Benefits for APOE ε4 Carriers
TL;DR: A 7-year randomized clinical trial found that combining telmisartan (blood pressure medication) and rosuvastatin (cholesterol medication) significantly reduced dementia risk and cognitive decline in elderly hypertensive patients. The combination was particularly effective for patients carrying the APOE ε4 gene variant, which is associated with increased dementia risk. Key Findings: This study provides strong evidence […]